Cell ReportsDevelopmental BiologyPeer-reviewed journal article
ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment
Jeffrey D. SteimleiD, Chul KimiD, Megan RowtoniD, Rangarajan D. Nadadur, Zhezhen WangiD, Matthew StockeriD, Andrew Daniel HoffmanniD, Erika Hanson, Junghun KweoniD, Tanvi SinhaiD, Kyunghee ChoiiD, Brian L. BlackiD, John M. CunninghamiD, Ivan P. G. MoskowitziD, Kohta IkegamiiD
Abstract
The lineage-determining transcription factor ETV2 is necessary and sufficient for hematoendothelial fate commitment. We investigated how ETV2-driven gene regulatory networks promote hematoendothelial fate commitment. We resolved the sequential determination steps of hematoendothelial versus cardiac differentiation from mouse embryonic stem cells. Etv2 was strongly induced and bound to the enhancers of hematoendothelial genes in a common cardiomyocyte-hematoendothelial mesoderm progenitor. However, only Etv2 itself and Tal1, not other ETV2-bound genes, were induced. Despite ETV2 genomic binding and Etv2 and Tal1 expression, cardiomyogenic fate potential was maintained. A second wave of ETV2-bound target genes was up-regulated during the transition from the common cardiomyocyte-hematoendothelial progenitor to the committed hematoendothelial population. A third wave of ETV-bound genes were subsequently expressed in the committed hematoendothelial population for sub-lineage differentiation. The shift from ETV2 binding to productive transcription, not ETV2 binding to target gene enhancers, drove hematoendothelial fate commitment. This work identifies mechanistic phases of ETV2-dependent gene expression that distinguish hematoendothelial specification, commitment, and differentiation. HIGHLIGHTSO_LIThe hematoendothelial master TF ETV2 is expressed in a multipotent mesoderm progenitor. C_LIO_LIETV2 binds to target genes in the mesoderm progenitor without target gene activation. C_LIO_LIETV2 binding in the mesoderm progenitor does not diminish alternative cardiac fate potential. C_LIO_LIETV2-bound target genes are activated upon hematoendothelial fate commitment. C_LI GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/449981v1_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@371c3dorg.highwire.dtl.DTLVardef@1ee8e7org.highwire.dtl.DTLVardef@14ca731org.highwire.dtl.DTLVardef@1748ff7_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: ChIP-seq
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: cell type annotation
- research focus: trajectory inference
- approach: statistical model
- approach: experimental assay
- Citations
- 14
- FWCI
- 1.15
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pioneer factor ETV2 safeguards endothelial cell specification by recruiting the repressor REST to restrict alternative lineage commitment
Danyang Chen, Xiaonuo Fan, … William T. Pu·Nature Cardiovascular ResearchPeer-reviewed·Jun 10, 2025
- ETV2 upregulation marks the specification of early cardiomyocytes and endothelial cells during co-differentiation
Xu Cao, Maria Mircea, … Valeria V. Orlova·Stem CellsPeer-reviewed·Dec 12, 2022
- CD82 expression marks the endothelium to hematopoietic transition at the onset of blood specification in human
Sara Menegatti, Bethany Potts, … Valérie Kouskoff·iSciencePeer-reviewed·Aug 9, 2023
- Targeted CRISPR-Cas9 screening identifies transcription factor network controlling murine haemato-endothelial fate commitment
Michael P. Teske, Tobias Wertheimer, … Nina Schmolka·bioRxiv·Jan 14, 2024
- Epigenetic control of coordinated hematopoietic and cardiovascular development by Rnf2 in zebrafish
- Endocardial differentiation in zebrafish occurs during early somitogenesis and is dependent on BMP and etv2 signalling
Samuel J. Capon, Kelly Smith·bioRxiv·May 30, 2019